Factors influencing standard pretravel health advice - A study in Belgium

Journal of Travel Medicine

Volumn 14, Issue 5, 2007, Pages 288-296

  Van De Winkel, Kristina ^a   Van Den Daele, Alex ^a   Van Gompel, Alfons ^a   Van Den Ende, Jef ^a,b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; LIVE VACCINE; MEFLOQUINE; PHENYTOIN; PROGUANIL; YELLOW FEVER VACCINE;

ADULT; ARTICLE; BELGIUM; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; RISK FACTOR; STOMACH PH; TRAVEL; TRAVELLER DIARRHEA; VACCINATION; YELLOW FEVER;

ADULT; AGE DISTRIBUTION; AGED; ANTIMALARIALS; BELGIUM; CHEMOPREVENTION; COMMUNICABLE DISEASE CONTROL; DIARRHEA; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALARIA; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TRAVEL; YELLOW FEVER;

EID: 34648843146     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2007.00141.x     Document Type: Article

References (40)

1. World Tourism Organization. Tourism highlights 2003. Available at : http://www.world-tourism.org/market_research/facts/menu.html Accessed 2006 Oct 10)
2. Visser L, Van Damme P. Epidemiologie van Reizigersziekten [Epidemiology of travellers' diseases]. In : Van Gompel A, Denekens J, eds. Reizen en Ziekte [Travel and illness]. Houten, The Netherlands : Bohn Stafleu van Loghum, 2000 : 3 11. Dutch publication.
3. Nationaal Instituut voor de Statistiek [National Institute for Statistics]. Toerisme: Reisonderzoek 2004 [Tourism: travel research 2004]. Available at : http://www.statbel.fgov.be/pub/d7/p731y2004_nl.pdf Accessed 2006 Dec 28). Dutch publication.
4. ITM year report 2004. Available at : http://www.itg.be/internet/ jaarverslag04/index.html Accessed 2004 Nov 3)
5. Stauffer WM, Konop RJ, Kamat D. Traveling with infants and young children. Part I: anticipatory guidance: travel preparation and preventive health advice. J Travel Med 2001 8 : 254 259.
6. Duval B, De Serre G, Shadmani R, et al. A population-based comparison between travellers who consulted travel clinics and those who did not. J Travel Med 2003 10 : 6 7.
7. Valerio L, Martinez O, Sabria M, et al. High-risk travel abroad overtook low-risk travel from 1999 to 2004: characterization and trends in 2,622 Spanish travellers. J Travel Med 2005 12 : 327 331.
8. Kemper CA, Linett A, Kane C, Deresinski SC. Frequency of travel of adults infected with HIV. J Travel Med 1995 2 : 85 88.
9. Greenberg A, Lobel H. Mortality from Plasmodium falciparum malaria in travellers from the United States, 1959 to 1987. Ann Intern Med 1990 113 : 326 327.
10. Muhlberger N, Jelinek T, Behrens RH, et al. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis 2003 36 : 990 995.
11. Steffen R, Rickenbach M, Willhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987 156 : 84 91.
12. Monath TP, Cetron MS. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 2002 34 : 1369 1378.
13. Centers of Disease Control and Prevention. Prevention of specific infectious diseases. In : Arguin P, Kozarsky P, Navin A, eds. Health information for international travel 2005-2006. Philadelphia: Elsevier Mosby, 2005 : 96 324.
14. Schlagenhauf P. Drugs used in malaria chemoprophylaxis: mefloquine. In : Schlagenhauf P, ed. Travellers' malaria. Hamilton, ON : BC Decker, 2001 : 163 260.
15. World Health Organization. Malaria. In : International travel and health. Geneva, Switzerland : WHO, 2005 : 130 148.
16. Loefler I. Mefloquine and anticoagulant interaction. J Travel Med 2003 10 : 194 195.
17. Bradley DJ, Bannister B. Guidelines for malaria prevention in travellers from the United Kingdom for 2003. Commun Dis Public Health 2003 6 : 192 193.
18. Rietveld A. Special groups: pregnant women, infants and young children. In : Schlagenhauf P, ed. Travellers' malaria. Hamilton, ON : BC Decker, 2001 : 303 323.
19. Centers of Disease Control and Prevention. Advising travellers with specific needs. In : Health information for international travel 2003-2004. Atlanta : US Department of Health and Human Services, Public Health Services, 2003 : 223 242.
20. Watson DAR. Pretravel health advice for asplenic individuals. J Travel Med 2003 10 : 117 121.
21. Conlon C. The immunocompromised traveller. In : DuPont H, Steffen R, eds. Textbook of travel medicine and health. London, UK : BC Decker, 2001 : 464 469.
22. Stürchler M. The vector and measures against mosquito bites. In : Schlagenhauf P, ed. Travellers' malaria. Hamilton, ON : BC Decker, 2001 : 119 148.
23. Bach O, Baier M, Pullwitt A, et al. Falciparum malaria after splenectomy: a prospective controlled study of 33 previously splenectomized Malawian adults. Trans R Soc Trop Med Hyg 2005 99 : 861 867.
24. Petithory JC, Khelil A, Galeazzi G, Ardoin F. Malaria in splenectomized patients. Three fatal cases [in French]. Presse Med 2005 34 : 519 521.
25. Toovey S, Jamieson A. Pretravel health advice for asplenic individuals. J Travel Med 2003 10 : 362 363.
26. Georgitis JW, Fasano MB. Allergenic components of vaccines and avoidance of vaccination-related adverse events. Curr Allergy Rep 2001 1 : 11 17.
27. Van Gompel A. HIV-positieve patiënten en andere patiënten met verminderde immuniteit. In : Dehaspe JP, ed. Gezondheidsadviezen voor reizigers [Health advice for travellers]. Medasso Headlines. Brussels, Belgium : Medimedia, 2004 : 156 157. Dutch publication.
28. Department of Health. Immunisation against infectious disease. London, UK : Crown Publications, 1996.
29. National Health and Medical Research Council (NHMRC). Vaccination for special risk groups. In : The Australian immunisation handbook. 8th Ed. Canberra, Australia : Australian Department of Health and Ageing, 2003 : 67 80.
30. Barwick R. History of thymoma and yellow fever vaccination. Lancet 2004 364 : 936.
31. Nasidi A, Monath TP, Vandenberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 1993 87 : 337 339.
32. Suzano CE, Amaral E, Sato HK, Papaiordanou PM. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine 2006 24 : 1421 1426.
33. Van Gompel A. Verplichte vaccinaties. In : Dehaspe JP, ed. Gezondheidsadviezen voor reizigers [Health advice for travelers]. Medasso Headlines. Brussels, Belgium : Medimedia, 2004 : 58 59. Dutch publication.
34. Centers for Disease Control and Prevention. Adverse Events Associated with 17D-Derived Yellow Fever Vaccination - United States, 2001-2002. MMWR 2002 51 : 989 993.
35. World Health Organization. Global Advisory Committee on Vaccine Safety, 2-3 December 2004-Yellow Fever. Wkly Epidemiol Rec 2005 6 7.
36. Suh K. The elderly traveler. In : Keystone J, Kozarsky P, Freedman D, Nothdurft H, eds. Travel medicine. Edinburgh, Scotland : Mosby, 2004 : 227 233.
37. McCarthy A. Travelers with pre-existing disease. In : Keystone J, Kozarsky P, Freedman D, Nothdurft H, eds. Travel medicine. Edinburgh, Scotland : Mosby, 2004 : 241 247.
38. Ligthelm R, van Thiel PP. The immunocompromised traveller. In : Zuckerman J, ed. Principles and practice of travel medicine. Chichester, UK : John Wiley and Sons Ltd, 2001 : 423 445.
39. Ostrosky-Zeichner L, Ericsson C. Travelers' diarrhea. In : Zuckerman J, ed. Principles and practice of travel medicine. Chichester, UK : John Wiley and Sons Ltd, 2001 : 153 163.
40. Oberhelman R, McLellan S, Behrens RH. Special hosts: children, pregnant women, immunocompromised patients, the elderly. In : Ericsson C, DuPont H, Steffen R, eds. Travelers' diarrhea. London, UK : BC Decker, 2003 : 240 257.